Kairos Pharma, Ltd.
KAPA
$1.66
$0.000.00%
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 16.08% | -21.17% | 2.36% | 1.69% | -12.68% |
| Total Depreciation and Amortization | -45.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -1.46% | 1.70% | -35.48% | -46.91% | 1,709.21% |
| Change in Net Operating Assets | -219.19% | 143.04% | -9.52% | 73.68% | -284.72% |
| Cash from Operations | 2.32% | 4.43% | -29.36% | -4.10% | -12.75% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -100.00% | 1,415.25% | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -116.82% | -- | -- | -- | -100.00% |
| Cash from Financing | -116.82% | -- | -100.00% | 1,415.25% | -92.71% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -28.55% | 24.72% | -142.66% | 536.60% | -124.83% |